English
简体中文
Total: £ 56.28
Published Date: 2026-04-01 | Pages: 127 | Tables: 127 | Medical Devices & Consumables
The global Expandable Cardiac Valvulotome market was valued at US$ 333 million in 2025 and is anticipated to reach US$ 545 million by 2032, at a CAGR of 7.4% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Expandable Cardiac Valvulotome competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global Expandable Cardiac Valvulotome production reached approximately 31,632 units, with an average global market price of around US$ 9,800 per unit.
The gross profit margin of major companies in the industry is between 45% – 62%.
Single-line production capacity is 6,000 – 12,000 units/year.
Expandable Cardiac Valvulotomes are minimally invasive surgical devices designed to enlarge stenotic cardiac valves by controlled blade expansion, improving blood flow during valve repair procedures. They allow precise cutting with reduced tissue trauma in cardiovascular surgery.
The industrial chain includes upstream stainless-steel micro-blades, balloon components, catheters, medical polymers, and precision actuators; midstream manufacturers assemble valvulotomes with imaging-compatible materials; downstream users include cardiovascular surgery centers, cardiac hospitals, and interventional therapy units, supported by clinical training and sterilization services.
The market for expandable cardiac valvulotomes is growing due to increasing prevalence of valvular heart diseases, aging populations, and demand for minimally invasive cardiovascular interventions. These tools provide controlled tissue cutting with lower trauma, making them preferred for valve repair in high-risk surgical patients. Advancements in catheter-based devices, imaging guidance, and micro-mechanical expansion systems improve safety and precision. Adoption is also supported by the expansion of cardiac specialty centers and rising awareness of early intervention for stenotic valve conditions. Manufacturers are investing in biocompatible materials, improved ergonomic designs, and hybrid valvulotome-balloon systems. Overall, the market is expected to maintain strong momentum as minimally invasive cardiac surgery continues to replace traditional open procedures.
This report delivers a comprehensive overview of the global Expandable Cardiac Valvulotome market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Expandable Cardiac Valvulotome. The Expandable Cardiac Valvulotome market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Expandable Cardiac Valvulotome market comprehensively. Regional market sizes by Type, by Application, by Expansion Mechanism, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Expandable Cardiac Valvulotome manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
LeMaitre
INVAMED
LimFlow, Inc.
B. Braun
Teleflex Incorporated
StarFish Medical
Koven Technology
BD
Symmetry Surgical
Andramed GmbH
OxSyBio
Segment by Type
Open-Surgery Valvulotome
Minimally Invasive Valvulotome
Guidewire-Assisted Valvulotome
Segment by Expansion Mechanism
Manual Expandable Valvulotome
Hydraulic Expandable Valvulotome
Self-Expanding Valvulotome
Segment by Blade Configuration
Single-Blade Valvulotome
Dual-Blade Valvulotome
Multi-Blade Valvulotome
by Application
Hospitals & Clinics
Cardiac Surgery Centers
Ambulatory Surgical Centers
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Expansion Mechanism, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Expandable Cardiac Valvulotome manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Expandable Cardiac Valvulotome sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Expandable Cardiac Valvulotome Market Overview
1.1 Product Definition
1.2 Expandable Cardiac Valvulotome by Type
1.2.1 Global Expandable Cardiac Valvulotome Market Value by Type: 2025 vs 2032
1.2.2 Open-Surgery Valvulotome
1.2.3 Minimally Invasive Valvulotome
1.2.4 Guidewire-Assisted Valvulotome
1.3 Expandable Cardiac Valvulotome by Expansion Mechanism
1.3.1 Global Expandable Cardiac Valvulotome Market Value by Expansion Mechanism: 2025 vs 2032
1.3.2 Manual Expandable Valvulotome
1.3.3 Hydraulic Expandable Valvulotome
1.3.4 Self-Expanding Valvulotome
1.4 Expandable Cardiac Valvulotome by Blade Configuration
1.4.1 Global Expandable Cardiac Valvulotome Market Value by Blade Configuration: 2025 vs 2032
1.4.2 Single-Blade Valvulotome
1.4.3 Dual-Blade Valvulotome
1.4.4 Multi-Blade Valvulotome
1.5 Expandable Cardiac Valvulotome by Application
1.5.1 Global Expandable Cardiac Valvulotome Market Value by Application: 2025 vs 2032
1.5.2 Hospitals & Clinics
1.5.3 Cardiac Surgery Centers
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Global Expandable Cardiac Valvulotome Market Size Estimates and Forecasts
1.6.1 Global Expandable Cardiac Valvulotome Revenue 2021–2032
1.6.2 Global Expandable Cardiac Valvulotome Sales 2021–2032
1.6.3 Global Expandable Cardiac Valvulotome Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Expandable Cardiac Valvulotome Market Competition by Manufacturers
2.1 Global Expandable Cardiac Valvulotome Sales Market Share by Manufacturers (2021–2026)
2.2 Global Expandable Cardiac Valvulotome Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Expandable Cardiac Valvulotome Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Expandable Cardiac Valvulotome, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Expandable Cardiac Valvulotome, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Expandable Cardiac Valvulotome, Product Types and Applications
2.7 Global Key Manufacturers of Expandable Cardiac Valvulotome, Date of Entry into the Industry
2.8 Global Expandable Cardiac Valvulotome Market Competitive Situation and Trends
2.8.1 Global Expandable Cardiac Valvulotome Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Expandable Cardiac Valvulotome Players Market Share by Revenue
2.8.3 Global Expandable Cardiac Valvulotome Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Expandable Cardiac Valvulotome Market Scenario by Region
3.1 Global Expandable Cardiac Valvulotome Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Expandable Cardiac Valvulotome Sales by Region: 2021–2032
3.2.1 Global Expandable Cardiac Valvulotome Sales by Region: 2021–2026
3.2.2 Global Expandable Cardiac Valvulotome Sales by Region: 2027–2032
3.3 Global Expandable Cardiac Valvulotome Revenue by Region: 2021–2032
3.3.1 Global Expandable Cardiac Valvulotome Revenue by Region: 2021–2026
3.3.2 Global Expandable Cardiac Valvulotome Revenue by Region: 2027–2032
3.4 North America Expandable Cardiac Valvulotome Market Facts & Figures by Country
3.4.1 North America Expandable Cardiac Valvulotome Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Expandable Cardiac Valvulotome Sales by Country (2021–2032)
3.4.3 North America Expandable Cardiac Valvulotome Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Expandable Cardiac Valvulotome Market Facts & Figures by Country
3.5.1 Europe Expandable Cardiac Valvulotome Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Expandable Cardiac Valvulotome Sales by Country (2021–2032)
3.5.3 Europe Expandable Cardiac Valvulotome Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Expandable Cardiac Valvulotome Market Facts & Figures by Region
3.6.1 Asia Pacific Expandable Cardiac Valvulotome Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Expandable Cardiac Valvulotome Sales by Region (2021–2032)
3.6.3 Asia Pacific Expandable Cardiac Valvulotome Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Expandable Cardiac Valvulotome Market Facts & Figures by Country
3.7.1 Latin America Expandable Cardiac Valvulotome Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Expandable Cardiac Valvulotome Sales by Country (2021–2032)
3.7.3 Latin America Expandable Cardiac Valvulotome Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Expandable Cardiac Valvulotome Market Facts & Figures by Country
3.8.1 Middle East and Africa Expandable Cardiac Valvulotome Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Expandable Cardiac Valvulotome Sales by Country (2021–2032)
3.8.3 Middle East and Africa Expandable Cardiac Valvulotome Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Expandable Cardiac Valvulotome Sales by Type (2021–2032)
4.1.1 Global Expandable Cardiac Valvulotome Sales by Type (2021–2026)
4.1.2 Global Expandable Cardiac Valvulotome Sales by Type (2027–2032)
4.1.3 Global Expandable Cardiac Valvulotome Sales Market Share by Type (2021–2032)
4.2 Global Expandable Cardiac Valvulotome Revenue by Type (2021–2032)
4.2.1 Global Expandable Cardiac Valvulotome Revenue by Type (2021–2026)
4.2.2 Global Expandable Cardiac Valvulotome Revenue by Type (2027–2032)
4.2.3 Global Expandable Cardiac Valvulotome Revenue Market Share by Type (2021–2032)
4.3 Global Expandable Cardiac Valvulotome Price by Type (2021–2032)
5 Segment by Application
5.1 Global Expandable Cardiac Valvulotome Sales by Application (2021–2032)
5.1.1 Global Expandable Cardiac Valvulotome Sales by Application (2021–2026)
5.1.2 Global Expandable Cardiac Valvulotome Sales by Application (2027–2032)
5.1.3 Global Expandable Cardiac Valvulotome Sales Market Share by Application (2021–2032)
5.2 Global Expandable Cardiac Valvulotome Revenue by Application (2021–2032)
5.2.1 Global Expandable Cardiac Valvulotome Revenue by Application (2021–2026)
5.2.2 Global Expandable Cardiac Valvulotome Revenue by Application (2027–2032)
5.2.3 Global Expandable Cardiac Valvulotome Revenue Market Share by Application (2021–2032)
5.3 Global Expandable Cardiac Valvulotome Price by Application (2021–2032)
6 Key Companies Profiled
6.1 LeMaitre
6.1.1 LeMaitre Company Information
6.1.2 LeMaitre Description and Business Overview
6.1.3 LeMaitre Expandable Cardiac Valvulotome Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 LeMaitre Expandable Cardiac Valvulotome Product Portfolio
6.1.5 LeMaitre Recent Developments/Updates
6.2 INVAMED
6.2.1 INVAMED Company Information
6.2.2 INVAMED Description and Business Overview
6.2.3 INVAMED Expandable Cardiac Valvulotome Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 INVAMED Expandable Cardiac Valvulotome Product Portfolio
6.2.5 INVAMED Recent Developments/Updates
6.3 LimFlow, Inc.
6.3.1 LimFlow, Inc. Company Information
6.3.2 LimFlow, Inc. Description and Business Overview
6.3.3 LimFlow, Inc. Expandable Cardiac Valvulotome Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 LimFlow, Inc. Expandable Cardiac Valvulotome Product Portfolio
6.3.5 LimFlow, Inc. Recent Developments/Updates
6.4 B. Braun
6.4.1 B. Braun Company Information
6.4.2 B. Braun Description and Business Overview
6.4.3 B. Braun Expandable Cardiac Valvulotome Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 B. Braun Expandable Cardiac Valvulotome Product Portfolio
6.4.5 B. Braun Recent Developments/Updates
6.5 Teleflex Incorporated
6.5.1 Teleflex Incorporated Company Information
6.5.2 Teleflex Incorporated Description and Business Overview
6.5.3 Teleflex Incorporated Expandable Cardiac Valvulotome Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Teleflex Incorporated Expandable Cardiac Valvulotome Product Portfolio
6.5.5 Teleflex Incorporated Recent Developments/Updates
6.6 StarFish Medical
6.6.1 StarFish Medical Company Information
6.6.2 StarFish Medical Description and Business Overview
6.6.3 StarFish Medical Expandable Cardiac Valvulotome Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 StarFish Medical Expandable Cardiac Valvulotome Product Portfolio
6.6.5 StarFish Medical Recent Developments/Updates
6.7 Koven Technology
6.7.1 Koven Technology Company Information
6.7.2 Koven Technology Description and Business Overview
6.7.3 Koven Technology Expandable Cardiac Valvulotome Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Koven Technology Expandable Cardiac Valvulotome Product Portfolio
6.7.5 Koven Technology Recent Developments/Updates
6.8 BD
6.8.1 BD Company Information
6.8.2 BD Description and Business Overview
6.8.3 BD Expandable Cardiac Valvulotome Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BD Expandable Cardiac Valvulotome Product Portfolio
6.8.5 BD Recent Developments/Updates
6.9 Symmetry Surgical
6.9.1 Symmetry Surgical Company Information
6.9.2 Symmetry Surgical Description and Business Overview
6.9.3 Symmetry Surgical Expandable Cardiac Valvulotome Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Symmetry Surgical Expandable Cardiac Valvulotome Product Portfolio
6.9.5 Symmetry Surgical Recent Developments/Updates
6.10 Andramed GmbH
6.10.1 Andramed GmbH Company Information
6.10.2 Andramed GmbH Description and Business Overview
6.10.3 Andramed GmbH Expandable Cardiac Valvulotome Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Andramed GmbH Expandable Cardiac Valvulotome Product Portfolio
6.10.5 Andramed GmbH Recent Developments/Updates
6.11 OxSyBio
6.11.1 OxSyBio Company Information
6.11.2 OxSyBio Description and Business Overview
6.11.3 OxSyBio Expandable Cardiac Valvulotome Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 OxSyBio Expandable Cardiac Valvulotome Product Portfolio
6.11.5 OxSyBio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Expandable Cardiac Valvulotome Industry Chain Analysis
7.2 Expandable Cardiac Valvulotome Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Expandable Cardiac Valvulotome Production Mode & Process Analysis
7.4 Expandable Cardiac Valvulotome Sales and Marketing
7.4.1 Expandable Cardiac Valvulotome Sales Channels
7.4.2 Expandable Cardiac Valvulotome Distributors
7.5 Expandable Cardiac Valvulotome Customer Analysis
8 Expandable Cardiac Valvulotome Market Dynamics
8.1 Expandable Cardiac Valvulotome Industry Trends
8.2 Expandable Cardiac Valvulotome Market Drivers
8.3 Expandable Cardiac Valvulotome Market Challenges
8.4 Expandable Cardiac Valvulotome Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Expandable Cardiac Valvulotome Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Expandable Cardiac Valvulotome Market Value by Expansion Mechanism (US$ Million), 2025 vs 2032
Table 3. Global Expandable Cardiac Valvulotome Market Value by Blade Configuration (US$ Million), 2025 vs 2032
Table 4. Global Expandable Cardiac Valvulotome Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Expandable Cardiac Valvulotome Market Competitive Situation by Manufacturers in 2025
Table 6. Global Expandable Cardiac Valvulotome Sales (Units) of Key Manufacturers (2021–2026)
Table 7. Global Expandable Cardiac Valvulotome Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Expandable Cardiac Valvulotome Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Expandable Cardiac Valvulotome Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Expandable Cardiac Valvulotome Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Expandable Cardiac Valvulotome, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Expandable Cardiac Valvulotome, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Expandable Cardiac Valvulotome, Product Types and Applications
Table 14. Global Key Manufacturers of Expandable Cardiac Valvulotome, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Expandable Cardiac Valvulotome Companies by Tier (Tier 1, Tier 2, Tier 3), based on Expandable Cardiac Valvulotome Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Expandable Cardiac Valvulotome Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Expandable Cardiac Valvulotome Sales by Region (Units), 2021–2026
Table 20. Global Expandable Cardiac Valvulotome Sales Market Share by Region (2021–2026)
Table 21. Global Expandable Cardiac Valvulotome Sales by Region (Units), 2027–2032
Table 22. Global Expandable Cardiac Valvulotome Sales Market Share by Region (2027–2032)
Table 23. Global Expandable Cardiac Valvulotome Revenue by Region (US$ Million), 2021–2026
Table 24. Global Expandable Cardiac Valvulotome Revenue Market Share by Region (2021–2026)
Table 25. Global Expandable Cardiac Valvulotome Revenue by Region (US$ Million), 2027–2032
Table 26. Global Expandable Cardiac Valvulotome Revenue Market Share by Region (2027–2032)
Table 27. North America Expandable Cardiac Valvulotome Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Expandable Cardiac Valvulotome Sales by Country (Units), 2021–2026
Table 29. North America Expandable Cardiac Valvulotome Sales by Country (Units), 2027–2032
Table 30. North America Expandable Cardiac Valvulotome Revenue by Country (US$ Million), 2021–2026
Table 31. North America Expandable Cardiac Valvulotome Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Expandable Cardiac Valvulotome Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Expandable Cardiac Valvulotome Sales by Country (Units), 2021–2026
Table 34. Europe Expandable Cardiac Valvulotome Sales by Country (Units), 2027–2032
Table 35. Europe Expandable Cardiac Valvulotome Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Expandable Cardiac Valvulotome Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Expandable Cardiac Valvulotome Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Expandable Cardiac Valvulotome Sales by Region (Units), 2021–2026
Table 39. Asia Pacific Expandable Cardiac Valvulotome Sales by Region (Units), 2027–2032
Table 40. Asia Pacific Expandable Cardiac Valvulotome Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Expandable Cardiac Valvulotome Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Expandable Cardiac Valvulotome Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Expandable Cardiac Valvulotome Sales by Country (Units), 2021–2026
Table 44. Latin America Expandable Cardiac Valvulotome Sales by Country (Units), 2027–2032
Table 45. Latin America Expandable Cardiac Valvulotome Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Expandable Cardiac Valvulotome Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Expandable Cardiac Valvulotome Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Expandable Cardiac Valvulotome Sales by Country (Units), 2021–2026
Table 49. Middle East and Africa Expandable Cardiac Valvulotome Sales by Country (Units), 2027–2032
Table 50. Middle East and Africa Expandable Cardiac Valvulotome Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Expandable Cardiac Valvulotome Revenue by Country (US$ Million), 2027–2032
Table 52. Global Expandable Cardiac Valvulotome Sales (Units) by Type (2021–2026)
Table 53. Global Expandable Cardiac Valvulotome Sales (Units) by Type (2027–2032)
Table 54. Global Expandable Cardiac Valvulotome Sales Market Share by Type (2021–2026)
Table 55. Global Expandable Cardiac Valvulotome Sales Market Share by Type (2027–2032)
Table 56. Global Expandable Cardiac Valvulotome Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Expandable Cardiac Valvulotome Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Expandable Cardiac Valvulotome Revenue Market Share by Type (2021–2026)
Table 59. Global Expandable Cardiac Valvulotome Revenue Market Share by Type (2027–2032)
Table 60. Global Expandable Cardiac Valvulotome Price (US$/Unit) by Type (2021–2026)
Table 61. Global Expandable Cardiac Valvulotome Price (US$/Unit) by Type (2027–2032)
Table 62. Global Expandable Cardiac Valvulotome Sales (Units) by Application (2021–2026)
Table 63. Global Expandable Cardiac Valvulotome Sales (Units) by Application (2027–2032)
Table 64. Global Expandable Cardiac Valvulotome Sales Market Share by Application (2021–2026)
Table 65. Global Expandable Cardiac Valvulotome Sales Market Share by Application (2027–2032)
Table 66. Global Expandable Cardiac Valvulotome Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Expandable Cardiac Valvulotome Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Expandable Cardiac Valvulotome Revenue Market Share by Application (2021–2026)
Table 69. Global Expandable Cardiac Valvulotome Revenue Market Share by Application (2027–2032)
Table 70. Global Expandable Cardiac Valvulotome Price (US$/Unit) by Application (2021–2026)
Table 71. Global Expandable Cardiac Valvulotome Price (US$/Unit) by Application (2027–2032)
Table 72. LeMaitre Company Information
Table 73. LeMaitre Description and Business Overview
Table 74. LeMaitre Expandable Cardiac Valvulotome Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. LeMaitre Expandable Cardiac Valvulotome Product
Table 76. LeMaitre Recent Developments/Updates
Table 77. INVAMED Company Information
Table 78. INVAMED Description and Business Overview
Table 79. INVAMED Expandable Cardiac Valvulotome Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. INVAMED Expandable Cardiac Valvulotome Product
Table 81. INVAMED Recent Developments/Updates
Table 82. LimFlow, Inc. Company Information
Table 83. LimFlow, Inc. Description and Business Overview
Table 84. LimFlow, Inc. Expandable Cardiac Valvulotome Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. LimFlow, Inc. Expandable Cardiac Valvulotome Product
Table 86. LimFlow, Inc. Recent Developments/Updates
Table 87. B. Braun Company Information
Table 88. B. Braun Description and Business Overview
Table 89. B. Braun Expandable Cardiac Valvulotome Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. B. Braun Expandable Cardiac Valvulotome Product
Table 91. B. Braun Recent Developments/Updates
Table 92. Teleflex Incorporated Company Information
Table 93. Teleflex Incorporated Description and Business Overview
Table 94. Teleflex Incorporated Expandable Cardiac Valvulotome Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. Teleflex Incorporated Expandable Cardiac Valvulotome Product
Table 96. Teleflex Incorporated Recent Developments/Updates
Table 97. StarFish Medical Company Information
Table 98. StarFish Medical Description and Business Overview
Table 99. StarFish Medical Expandable Cardiac Valvulotome Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. StarFish Medical Expandable Cardiac Valvulotome Product
Table 101. StarFish Medical Recent Developments/Updates
Table 102. Koven Technology Company Information
Table 103. Koven Technology Description and Business Overview
Table 104. Koven Technology Expandable Cardiac Valvulotome Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. Koven Technology Expandable Cardiac Valvulotome Product
Table 106. Koven Technology Recent Developments/Updates
Table 107. BD Company Information
Table 108. BD Description and Business Overview
Table 109. BD Expandable Cardiac Valvulotome Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. BD Expandable Cardiac Valvulotome Product
Table 111. BD Recent Developments/Updates
Table 112. Symmetry Surgical Company Information
Table 113. Symmetry Surgical Description and Business Overview
Table 114. Symmetry Surgical Expandable Cardiac Valvulotome Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. Symmetry Surgical Expandable Cardiac Valvulotome Product
Table 116. Symmetry Surgical Recent Developments/Updates
Table 117. Andramed GmbH Company Information
Table 118. Andramed GmbH Description and Business Overview
Table 119. Andramed GmbH Expandable Cardiac Valvulotome Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. Andramed GmbH Expandable Cardiac Valvulotome Product
Table 121. Andramed GmbH Recent Developments/Updates
Table 122. OxSyBio Company Information
Table 123. OxSyBio Description and Business Overview
Table 124. OxSyBio Expandable Cardiac Valvulotome Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. OxSyBio Expandable Cardiac Valvulotome Product
Table 126. OxSyBio Recent Developments/Updates
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Expandable Cardiac Valvulotome Distributors List
Table 130. Expandable Cardiac Valvulotome Customers List
Table 131. Expandable Cardiac Valvulotome Market Trends
Table 132. Expandable Cardiac Valvulotome Market Drivers
Table 133. Expandable Cardiac Valvulotome Market Challenges
Table 134. Expandable Cardiac Valvulotome Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Authors List of This Report
List of Figures
Figure 1. Product Picture of Expandable Cardiac Valvulotome
Figure 2. Global Expandable Cardiac Valvulotome Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Expandable Cardiac Valvulotome Market Share by Type: 2025 & 2032
Figure 4. Open-Surgery Valvulotome Product Picture
Figure 5. Minimally Invasive Valvulotome Product Picture
Figure 6. Guidewire-Assisted Valvulotome Product Picture
Figure 7. Global Expandable Cardiac Valvulotome Market Value by Expansion Mechanism (US$ Million), 2021–2032
Figure 8. Global Expandable Cardiac Valvulotome Market Share by Expansion Mechanism: 2025 vs 2032
Figure 9. Manual Expandable Valvulotome Product Picture
Figure 10. Hydraulic Expandable Valvulotome Product Picture
Figure 11. Self-Expanding Valvulotome Product Picture
Figure 12. Global Expandable Cardiac Valvulotome Market Value by Blade Configuration (US$ Million), 2021–2032
Figure 13. Global Expandable Cardiac Valvulotome Market Share by Blade Configuration: 2025 vs 2032
Figure 14. Single-Blade Valvulotome Product Picture
Figure 15. Dual-Blade Valvulotome Product Picture
Figure 16. Multi-Blade Valvulotome Product Picture
Figure 17. Global Expandable Cardiac Valvulotome Market Value by Application (US$ Million), 2021–2032
Figure 18. Global Expandable Cardiac Valvulotome Market Share by Application: 2025 & 2032
Figure 19. Hospitals & Clinics
Figure 20. Cardiac Surgery Centers
Figure 21. Ambulatory Surgical Centers
Figure 22. Others
Figure 23. Global Expandable Cardiac Valvulotome Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Expandable Cardiac Valvulotome Market Size (US$ Million), 2021–2032
Figure 25. Global Expandable Cardiac Valvulotome Sales (Units), 2021–2032
Figure 26. Global Expandable Cardiac Valvulotome Average Price (US$/Unit), 2021–2032
Figure 27. Expandable Cardiac Valvulotome Report Years Considered
Figure 28. Expandable Cardiac Valvulotome Sales Share by Manufacturers in 2025
Figure 29. Global Expandable Cardiac Valvulotome Revenue Share by Manufacturers in 2025
Figure 30. Top 5 and Top 10 Global Expandable Cardiac Valvulotome Players: Market Share by Revenue in Expandable Cardiac Valvulotome in 2025
Figure 31. Expandable Cardiac Valvulotome Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 32. Global Expandable Cardiac Valvulotome Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 33. North America Expandable Cardiac Valvulotome Sales Market Share by Country (2021–2032)
Figure 34. North America Expandable Cardiac Valvulotome Revenue Market Share by Country (2021–2032)
Figure 35. United States Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Canada Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Europe Expandable Cardiac Valvulotome Sales Market Share by Country (2021–2032)
Figure 38. Europe Expandable Cardiac Valvulotome Revenue Market Share by Country (2021–2032)
Figure 39. Germany Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. France Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. U.K. Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Italy Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Russia Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Asia Pacific Expandable Cardiac Valvulotome Sales Market Share by Region (2021–2032)
Figure 45. Asia Pacific Expandable Cardiac Valvulotome Revenue Market Share by Region (2021–2032)
Figure 46. China Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Japan Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. South Korea Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. India Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Australia Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. China Taiwan Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Southeast Asia Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Latin America Expandable Cardiac Valvulotome Sales Market Share by Country (2021–2032)
Figure 54. Latin America Expandable Cardiac Valvulotome Revenue Market Share by Country (2021–2032)
Figure 55. Mexico Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Brazil Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Argentina Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Colombia Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Middle East and Africa Expandable Cardiac Valvulotome Sales Market Share by Country (2021–2032)
Figure 60. Middle East and Africa Expandable Cardiac Valvulotome Revenue Market Share by Country (2021–2032)
Figure 61. Turkey Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Saudi Arabia Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. UAE Expandable Cardiac Valvulotome Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. Global Sales Market Share of Expandable Cardiac Valvulotome by Type (2021–2032)
Figure 65. Global Revenue Market Share of Expandable Cardiac Valvulotome by Type (2021–2032)
Figure 66. Global Expandable Cardiac Valvulotome Price (US$/Unit) by Type (2021–2032)
Figure 67. Global Sales Market Share of Expandable Cardiac Valvulotome by Application (2021–2032)
Figure 68. Global Revenue Market Share of Expandable Cardiac Valvulotome by Application (2021–2032)
Figure 69. Global Expandable Cardiac Valvulotome Price (US$/Unit) by Application (2021–2032)
Figure 70. Expandable Cardiac Valvulotome Value Chain
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
